EpiVax, Inc. is proud to announce the appointment of Guilhem Richard as Chief Technology Officer. Dr. Richard joined EpiVax's Immunoinformatics team in 2014 and led the...
EpiVax, Inc. ("EpiVax") announces the publication "Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity"...
